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Objectives. This study investigated the value of sestamibi 
scintigraphy in assessing residual ischemia fter anterior myo- 
cardial infarction. 
Background. Serial imaging with sestamibi, the uptake and 
retention of which correlate with regional myocardial blood flow 
and viability, has been used to estimate salvaged myocardium and 
risk area after acute infarction. We recently documented that 
recovery of perfusion and contraction in the infarcted area may 
continue well after the subacute phase, suggesting myocardial 
hibernation. Some underestimation f viability in the setting of 
hibernating myocardium by sestamibi imaging has been reported. 
Methods. We studied 58 patients in stable condition after Q 
wave anterior infarction. Regional perfusion and function were 
quantitatively assessed by sestamibi tomography and two- 
dimensional echocardiography at 4 to 6 weeks and at 7 months 
after infarction. In sestamibi polar maps, abnormal areas with 
tracer uptake >2.5 SD below our reference values were computed 
at rest and after symptom-limited xercise. On two-dimensional 
echocardiography the ejection fraction and extent of rest wall 
motion abnormalities were assessed by a computerized system. All 
patients had coronary angiography between the two studies. 
Results. At 7 months the extent of rest sestamibi defect was 
significantly reduced in 40 patients (69%, group 1) and unchanged 
in 18 (31%, group 2). Rest wall motion abnormalities and ventric- 
ular ejection fraction significantly improved in group 1 but not in 
group 2. Underlying coronary disease, patency of the infarct. 
related vessel and rest sestamibi defect extent at 5 weeks were 
comparable between the two groups. At 7 months, an increase in 
the reversible (stress-rest defect) tracer defect was observed in 
group 1 (p < 0.05) despite asmaller stress-induced hypoperfusion 
(p < 0.05). Reversible sestamibi defects and stress hypoperfusion 
were unchanged ingroup 2. In 38 (95%) of 40 group 1 patients, the 
area showing reversible sestamibi defects at 7 months matched 
the area showing fixed hypoperfusion at5 weeks. 
Conclusions. The reduction in the rest tracer uptake defect that 
can occur late after infarction may affect the assessment of 
ischemic burden by sestamibi imaging early after anterior myo- 
cardial infarction. 
(J Am Coil Cardiol 1995;25:590-6) 
In the management of patients with ischemic heart disease and 
abnormal rest electrocardiographic (ECG) results, stress im- 
aging techniques can be preferable to exercise lectrocardio- 
graphy alone (1). Patients with anterior Q wave infarction are 
frequently referred for radionuclide study because ST segment 
shifts on exercise stress testing cannot reliably identify the 
presence of residual ischemia (2,3). 
Technetium-99m methoxyisobutylisonitrile (sestamibi) is a 
myocardial perfusion agent whose uptake and retention cor- 
relate closely with regional myocardial blood flow and tissue 
viability (4-6). Recent clinical studies have demonstrated its
usefulness in assessing the risk area during the acute phase of 
From the Cardiology Division and Nuclear Medicine Laboratory, Clinica del 
Lavoro Foundation, Istituto Ricovero e Cura a Caranere Scientifico (1RCCS), 
Veruno, Italy. This study was supported in part by Grant Ricerca Corrente 
1992/93 from the Ministero della Sanit~i, Rome, Italy. 
Manuscript received January 6, 1994; revised manuscript received July 15, 
1994, accepted October 3, 1994. 
Address for corresnondence: Dr. Claudio Marcassa, Cardiology Division, 
Fondazione Clinica del Lavoro, via Revislate 13, Veruno 28010 (No), Italy. 
myocardial infarction (7,8) and in determining the efficacy of 
various reperfusion strategies (9,10). The changes in the size 
and severity of the perfusion defect assessed by serial sestamibi 
imaging after thrombolytic therapy have been used to estimate 
salvaged myocardium and, thereby, patency of the infarct- 
related vessel (11,12). 
However, the time course of the recovery of myocardial 
perfusion and function after myocardial infarction and its 
effect on the detection of residual ischemia remain unclear. 
Indeed, we recently documented (13) that recovery of perfu- 
sion and contraction i  the infarcted area may continue well 
after the subacute phase in a sizable number of patients with 
recent anterior infarction, suggesting myocardial hibernation. 
Moreover, underestimation f myocardial viability in the set- 
ting of hibernating myocardium by sestamibi maging has 
recently been acknowledged (14-17). 
The aim of this study was to investigate the possible effects 
of the evolving tomographic estimate of myocardial "infarct 
area" by sestamibi on the assessment of residual ischemia in a 
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selected group of patients with a first Q wave anterior myo- 
cardial infarction. 
Methods  
Study cohort. We prospectively studied 58 male patients 
(49 + 8 years) with recent anterior myocardial infarction who 
met the following inclusion criteria: 1) history of a recent (4 to 
6 weeks) first Q wave anterior myocardial infarction; 2) New 
York Heart Association functional class I or II; 3) no angina t 
rest; 4) sinus rhythm and no conduction disturbances; and 
5) two-dimensional echocardiographic images of adequate 
quality for quantitative analysis. The diagnosis of acute myo- 
cardial infarction was supported by typical history of chest pain 
(>30 min), abnormal Q waves in at least two adjacent precor- 
dial leads and in lead I or aVL, or both, and a typical pattern 
of elevated serum myocardial enzymes. Patients with unstable 
angina, low threshold ischemia or angina uncontrolled by 
medical therapy, as well as those with severe left ventricular 
dysfunction (rest ejection fraction <25%), were excluded. Rest 
scintigraphic and echocardiographic data from 52 of these 
patients were included in a previous report (13). 
Study protocol. Regional myocardial perfusion was evalu- 
ated with sestamibi single-photon emission tomography atrest 
and after exercise. Left ventricular function was assessed at 
rest by two-dimensional echocardiography. Resting sestamibi 
and echocardiographic studies were performed on the same 
day; exercise scintigraphy was performed within 24 h. All 
patients underwent the scintigraphic and echocardiographic 
studies 4 to 6 weeks after the necrotic episode (study 1) and 
then 6 months later (study 2). Patients had to be in stable 
condition during the interval between the two studies. Cardio- 
active drugs were discontinued at least 48 h before each 
evaluation. The study protocol was approved by the local 
Ethical Committee on Human Research, and written informed 
consent was obtained from all patients. 
Sestamibi maging and analysis. For both study 1 and 
study 2, a 2-day imaging protocol was used for rest and exercise 
scans (in a random order). A multistage symptom-limited 
exercise was performed; a 12-lead ECG was recorded every 
minute and blood pressure very 3 min. An incremental load of 
25 W was given every 3 min; at peak exercise, the tracer was 
injected intravenously, after which patients were encouraged 
to continue xercising for 60 to 90 s. 
The method of sestamibi scan acquisition and processing 
has recently been described (13). Briefly, both the rest and 
exercise scintigraphic image acquisitions were performed 
within 90 to 120 min from the tracer injection (925 
MBq/70 kg). The camera head (Apex 409, Elscint, Israel) was 
rotated in a 180 ° arc in a circular orbit with 3 ° increments of 
25 s in a step-and-shoot mode. Data were collected in a 64 × 
64 array with a pixel size of 4.5 ram. Particular care was taken 
to avoid major artifacts, such as patient motion during acqui- 
sition. Transaxial slices were reconstructed using a filtered 
back-projection algorithm with a modified Wiener filter with- 
out attenuation or scatter correction; flood correction was 
applied during reconstruction. The spatial resolution in the 
transaxial plane was 8 mm. Short- and long-axis (horizontal 
and vertical) tomograms were reconstructed from the transaxial 
slices. Slices in the short-axis view were reconstructed, and polar 
maps of regional sestamibi distribution were displayed, both at 
rest and after exercise. Each polar map was normalized for peak 
myocardial ctivity and compared with our normal imits: Pixels 
with tracer uptake <2.5 SD below mean normal values were 
considered abnormal. The abnormal area on each short-axis slice 
was first multiplied by a correction factor (18) that corrects the 
spatial distortion and allows for differences in myocardial slice 
mass from apex to base. Corrected abnormal areas were then 
summed to obtain the total size of left ventricular defect at rest 
and after exercise, expressed as a percent of the left ventricular 
surface. Changes in the perfusion defect size from study 1 to study 
2 and from rest to exercise studies were considered significant 
when they exceeded the 95% confidence limits of the method 
variability (13). 
Echocardiographic data acquisition and analysis. Our 
methods of data acquisition and image digitalization and the 
computerized system for the automatic detection and quanti- 
fication of regional wall motion and left ventricular function 
have been previously described (19,20). Briefly, the three 
apical views (four and two chambers and apical ong axis) were 
analyzed. The endocardial contour of each view was automat- 
ically divided into 23 segments of equal length, so that the 
entire ventricular wall was represented by a total of 69 
segments. By comparison with our normal data base, the 
presence of abnormal wall motion was automatically detected 
when the fractional shortening area from end-diastole to 
end-systole of each segment decreased 2 SD of the mean 
values in normal subjects. The extent of wall motion abnor- 
malities was expressed as a percent of total endocardial length. 
Left ventricular ejection fraction was calculated using the 
biplane area-length method. All measurements were derived 
in blinded manner by a single experienced operator f om three 
consecutive cardiac ycles, and the mean values were consid- 
ered. Intraobserver variability values in endocardial contouring 
and in the evaluation of end-systolic and end-diastolic endo- 
cardial surface area by our quantitative analysis in normal 
subjects and in patients with different degrees of left ventric- 
ular dysfunction have been reported elsewhere (21). 
Coronary angiography. All patients underwent cardiac 
catheterization bythe Judkins technique during the 6-month 
interval between the two studies (on average 95 _+ 12 days from 
study 1). After intracoronary administration of nitroglycerin, 
selective angiograms were obtained in at least two projections 
for the right coronary artery and in at least four for the left 
coronary artery. The presence of a significant (>50% coronary 
diameter reduction) stenosis was assessed using caliper mea- 
surements in two orthogonal projections by one experienced 
investigator who had no other information. The Thrombolysis 
in Myocardial Infarction (TIMI) grade of the infarct-related 
vessel patency was determined (0to 1 = occluded artery; 2 to 
3 = patent artery). The presence of collateral circulation was 
also assessed. 
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Table 1. Clinical Characteristics of the 58 Study Patients 
Age (yr) 49 _+ 8 
History of 
Smoking 39 (67%) 
Hypertension 14 (24%) 
Diabetes 5 (9%) 
Acute phase of infarction 
Systemic thrombolysis 42 (72%) 
Peak serum CK (IU/ml) 3,472 _+ 2,181 
KiUip class I 51 (82%) 
Killip class II 7 (12%) 
Medications 
Beta-blockers 42 (72%) 
Nitrates 16 (27%) 
ACE inhibitors 5 (9%) 
Calcium channel blockers 5 (9%) 
Data presented are mean value _+ SD or number (%) of patients. ACE - 
angiotensin-converting enzyme; CK = creatinine kinase. 
The vascular attribution of scintigraphic and echocardio- 
graphic regions to the conventional natomic distribution of 
the major coronary arteries was performed according to the 
division proposed by the Cedars-Sinai Laboratory (22) and the 
American Society of Echocardiography (23), respectively. 
Statistical analysis. Data are reported as mean value +_ 
SD. Normality of the data distribution was verified. The extent 
of the sestamibi perfusion defects at rest and after exercise, left 
ventricular volumes, ejection fraction and percent wall motion 
abnormality at studies 1 and 2 were compared using the 
Student t test for paired data. Baseline characteristics between 
groups were compared using the unpaired Student  test for 
continuous variables and the chi-square test to determine the 
significance of differences in rates of occurrence. For inter- 
group comparisons of scintigraphic and echocardiographic 
variables at studies 1 and 2, a one-way analysis of variance 
combined with the Scheff6 test was used; p < 0.05 (two-tailed) 
was considered significant. 
Resu l ts  
Of the 66 patients who underwent rest and stress estamibi 
imaging 5 weeks after infarction, 2 died in the subsequent 
months (1 of sudden cardiac death, 1 of cancer); 6 others 
showed a high risk exertional scintigraphic pattern (as defined 
by multiple perfusion defects) and soon underwent coronary 
artery bypass graft surgery or coronary angioplasty because of 
clinical worsening or extensive coronary disease. The remain- 
ing 58 medically treated patients underwent coronary angiog- 
raphy and completed the serial protocol 6 months later while 
in stable condition. Their clinical characteristics are reported 
in Table 1. 
Coronary anatomy. Significant stenoses involving one and 
two vessels were found in 39 (67%) and 14 (24%) patients, 
respectively. In five patients (9%), no significant residual 
stenosis was documented. The infarct-related vessel stenosis 
affected the proximal left anterior descending coronary artery 
in 25 patients (47%) and its mid to distal portion in 28 (53%); 
angiographically visible collateral vessels toward the infarct- 
related vessel were observed in 20 patients (38%). 
Serial rest sestamibi and echocardiographic results. At 
study 1, all patients howed sestamibi uptake defects and wall 
motion abnormalities inthe region supplied by the left anterior 
descending coronary artery. The extent of hypoperfused left 
ventricle ranged from 2% to 55%; the percent wall motion 
abnormality ranged from 4% to 61%. At study 2, the entire 
study cohort had a significant reduction in the extent of 
perfusion defect (from 33 _+ 13% to 26 _+ 16%, p < 0.001) and 
percent wall motion abnormality (from 35 _+ 15% to 31 _+ 
19%, p < 0.01) as well as a significant improvement in left 
ventricular ejection fraction values (from 48 _+ 13% to 50 _+ 
15%, p < 0.01). 
According to the changes in the rest perfusion defect from 
study 1 to study 2, sestamibi defect was smaller in 40 patients 
(69%, group 1) and unchanged in 18 (31%, group 2). There 
were no significant differences in perfusion defect extent 
between the two groups at study 1; however, group 2 patients 
had a significantly ower ejection fraction and higher percent 
wall motion abnormality (Table 2). At study 2, there was a 
significant improvement i  the percent wall motion abnormal- 
ity and ejection fraction in group 1 but not in group 2 patients. 
Other clinical and angiographic haracteristics of the two 
groups are reported in Table 3. Age, thrombolysis in the acute 
phase, extent of underlying coronary disease, TIMI grade of 
the infarct vessel patency and collateral vessels to the infarct- 
related vessel were comparable between the two groups. 
Serial exercise sestamibi results. Significant ECG changes 
(ST segment depression >1 ram), chest pain and reversible 
Table 2. Scintigraphic and Echocardiographic Data at 4 to 6 Weeks (study 1) and at 7 Months (study 2) 
After Infarction i Patients With (group 1) and Without (group 2) Improvement i  Rest 
Sestamibi Uptake 
Group 1 (n - 40) Group 2 (n = 18) 
Study l Study 2 Study 1 Study 2 
Sestamibi defect extent at rest (%) 33 _+ 14 23 + 15" 33 +_ 13 36 _+ 19] 
Left ventricular ejection fraction (%) 50 _+ 13 53 _+ 14" 42 ~ 10t 43 + 12 
Wall motion abnormalities (%) 33 _+ 16 28 + 20~: 39 + 12]. 38 = 14 
*p < 0.001 and :~p < 0.01 versus tudy 1. tp < 0.05 versus group 1 at corresponding time. Data presented are mean 
value _+ SD. 
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Table 3. Clinical and Angiographic Findings in Patients With (group 
1) and Without (group 2) Improvement in Rest Sestamibi Uptake 
Defect After 6 Months 
Group 1 Group 2 
(n = 40) (n = 18) p Value 
Age (yr) 49 -+ 7 47 -+ 10 NS 
Acute phase of infarction 
Peak serum CK (IU/ml) 2,666 + 1,978 4,276 + 2,385 <0.05 
Thrombolysis 29 (72%) 13 (72%) NS 
Coronary angiography 
No CAD 3 (8%) 2 (11%) 
Single LAD disease 27 (66%) 12 (67%) 
Double-vessel disease 10 (25%) 4 (22%) 
Infarct vessel 
TIMI grade 1.8 _+ 1.3 1.6 _+ 1.5 
Patency 21 (54%) 9 (50%) 
Collateral vessels 13 (33%) 7 (39%) 
NS 
NS 
NS 
NS 
Data presented are mean value _+ SD or number (%) of patients. CAD = 
coronary artery disease; CK creatine kinase; LAD = left anterior descending 
coronary artery.; TIMI = Thrombolysis n Myocardial Infarction. 
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Figure 1. Extent of exercise-inducible "reversible" sestamibi defect 
(i.e., stress-rest percent of the total abnormal left ventricular surface) 
at 4- to 6-week imaging (study 1, open bars) and 6 months later (study 
2, solid bars) in the general study cohort and in the two groups of 
patients. Data are reported as mean percent units _+ SE. *p < 0.05 
versus study 1. 
(exercise-rest) perfusion defects were observed in study 1 in 13 
(22%), 3 (5%) and 52 (90%) patients, respectively. In study 2, 
significant ST segment changes, chest pain and reversible 
tracer defects were observed in 15 (26%), 2 (3%) and 43 (74%) 
patients, respectively (p = NS vs. study 1). Overall, the extent 
of the reversible sestamibi defect was unchanged at study 2 
(10 + 9% vs. 8 _+ 8% at study 1, p = NS) despite the significant 
reduction in the stress hypoperfusion extent (from 41 _+ 11% 
to 36 _+ 14% at study 2, p < 0.001). 
Ergometric results and exercise scintigraphic data at studies 
i and 2 in groups 1 and 2 are summarized inTable 4. In group 
1, a significantly greater extent of reversible tracer uptake 
defect was evident at study 2 (Fig. 1), although the actual stress 
hypoperfusion was smaller than in study 1. In 38 (95%) of 40 
group 1 patients, the area showing reversible sestamibi defect 
at study 2 matched the area showing a fixed perfusion defect at 
study 1 (Fig. 2). Four of five patients who bad fixed perfusion 
defect only at study 1 showed reversible sestamibi defects in 
myocardial areas previously classified as scarred. 
In group 2, by contrast, the extent of the reversible sesta- 
mibi defect was significantly reduced at study 2 (p < 0.05, Fig. 
1) as a result of a small and nonsignificant (p = 0.07) increase 
in the rest defect and without significant changes in the 
stress-induced hypoperfusion. 
Discuss ion  
The determination of the final infarct size and the assess- 
ment of residual iscbemia have important implications for the 
risk stratification of patients with recent myocardial infarction. 
Because of the presence of both myocardial stunning and 
hyperdynamic ventricular function, predischarge left ventricu- 
lar ejection fraction and wall motion analysis may be mislead- 
ing. To assess both residual viability and ischemia in jeopar- 
dized areas, stress-rest quantitative myocardial perfusion 
imaging is frequently used. Our results indicate that at serial 
sestamibi maging, an apparent increase in the ischemic area 
frequently occurs late after acute infarction in patients in 
stable condition because areas that appear to be scarred at 5 
weeks appear viable and ischemic 6 months later. 
Sestamibi estimate of infarct size. Sestamibi uptake and 
retention are sensitive and proportional to regional myocardial 
Table 4. Ergometric Results at 4 to 6 Weeks (study 1) and at 7 Months (study 2) After Infarction 
Group l (n - 40) Group 2 (n = 18) 
Study 1 Study 2 Study 1 Study 2 
Exercise duration (min) 11.7 -+ 1.7 12.2 -+ 1.6 11.5 -+ 1.6 12.6 _+ 2.3* 
Rate-pressure product 24,855 _+ 4,277 24,050 _+ 4,488 24,673 _+ 4,778 24,284 _+ 5,517 
Chest pain 3 (8%) 2 (5%) 0 0 
ST segment depression >1 mm 10 (25%) 11 (28%) 3 (17%) 4 (22%) 
Reversible sestamibi defects 35 (87%) 32 (84%) 17 (94%) 11 (78%) 
Exercise sestamibi defect extent (%) 40 _+ 11 35 _+ 14t 42 _+ 9 42 + 12~ 
Reversible sestamibi defect extent 7 + 7 11 + 9* 10 + 8 5 _+ 6* 
(exercise-rest defect) (%) 
*p < 0.05, tp < 0.001 versus tudy 1. l:p < 0.05 versus group 1 at corresponding time. Data presented are mean 
value _+ SD or number (%) of patients. 
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Figure 2. Rest and stress tomographic sestamibi im- 
ages 5 weeks after acute infarction and 6 months later 
in a group 1 patient with a suboccluded mid-anterior 
descending coronary artery (Thrombolysis in Myocar- 
dial Infarction flow grade 0; no collateral vessels were 
seen at angiography). The rest racer uptake defect, 
which involves the anteroseptal wall and the apex on 
5-week images, isdefinitively reduced 6 months later. 
Although the 5-week stress images failed to show 
further hypoperfusion after exercise, an evident s ress- 
induced perfusion defect is shown 6 months later in 
the area previously interpreted as"scarred." 
blood flow and tissue viability (3-6). The chemical and physical 
properties of Tc-99m sestamibi make it an ideal agent for the 
assessment of myocardium atrisk (5,7). In animal models of 
coronary occlusion and reperfusion, the tracer injection during 
occlusion yielded accurate stimates of the myocardium atrisk 
as well as reliable measurements of the final infarct size when 
injected after reperfusion. In the setting of acute myocardial 
infarction in humans, serial changes in myocardial perfusion 
assessed by sestamibi imaging have been used as a measure of 
myocardial salvage in evaluating the efficacy of thrombolytic 
therapy (8-10), for the comparison of various reperfusion 
strategies (10,11) and for assessing the patency of the infarct- 
related artery (12). However, Pellikka et al. (24) reported a
progressive reduction in the amount of hypoperfused myocar- 
dium from the tomographic study at 18 to 48 h to a later study 
at 6 to 14 days in patients with acute myocardial infarction who 
received thrombolytic therapy. We recently documented (13) a 
significant reduction in the rest sestamibi defect size in the 
infarcted area in a consistent percent of patients with stable 
coronary artery disease over a 6-month period after myocardial 
infarction. These findings of improved tracer distribution in 
the infarct area late after acute infarction suggest some 
delayed improvement of the blood flow supply to the infarcted 
area. 
In the present study, half of the patients who showed 
improved sestamibi distribution in the infarcted area at study 2 
had severe (>90%) infarct-related vessel stenosis. In the 
presence of such severe coronary obstruction, the preservation 
of rest blood flow in the jeopardized area has been related to 
a maintained coronary reserve (25). In patients with stable 
coronary artery disease, several clinical studies documented 
reduced levels of rest myocardial perfusion in the absence of 
either acute myocardial ischemia or necrosis (26-28). How- 
ever, even in the absence of severe residual stenosis of the 
infarct-related vessel, an impaired coronary reserve could still 
affect blood flow to the salvaged myocardium and, conse- 
quently, sestamibi delivery. Brief periods of ischemia have 
been shown to cause prolonged impairment of coronary vaso- 
dilation (microvascular stunning) in addition to myocardial 
stunning (29,30). 
Hibernating myocardium and residual isehemia. In our 
study, the reduction in the rest hypoperfused area was associ- 
ated with an improvement in regional percent wall motion 
abnormality and left ventricular ejection fraction, suggesting 
that the observed reperfusion affected the dysfunctioning but 
salvaged myocardium that would improve thereafter (hibernat- 
ing myocardium). In the setting of hibernating myocardium, 
underestimation f residual myocardial viability through the 
use of rest sestamibi imaging compared with rest or 24-h 
thallium-201 redistribution images (16,17) or metabolic 
fluorine-18 deoxyglucose imaging (14,15) has been reported. 
The assessment of residual viability may be flawed by the use 
of a tracer whose distribution is largely perfusion dependent 
and that redistributes minimally (4,31,32). Indeed, changes in 
blood flow supply can influence the resting tracer distribution. 
A decreased sestamibi uptake is often reversible after nitro- 
glycerin administration (33) or coronary revascularization (34). 
However, different results have also been reported regarding 
the accuracy of sestamibi imaging to determine myocardial 
viability. Rest sestamibi distribution was found to compare 
favorably with delayed thallium-201 redistribution i  an exper- 
imental model of sustained flow reduction, minimal necrosis 
and profound ischemic dysfunction (35). Furthermore, in a 
scintigraphic-pathologic study in patients undergoing cardiac 
transplantation, the size of the rest sestamibi defect correlated 
closely with the amount of histologic fibrosis (36). 
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In the present study, the late recovery of perfusion and 
contraction i the infarcted area was unrelated to the extent of 
underlying coronary disease, thrombolysis in the acute phase, 
TIMI grade of the infarct-related vessel or presence of collat- 
eral vessels on angiography. In interpreting our finding of some 
late "reperfusion" of the infarcted area, another explanation 
deserves mention. It has recently been documented (37,38) 
that "apparent" perfusion defects on ungated scintigraphic 
images can occur as a result of abnormal segmental contrac- 
tion despite preserved regional myocardial blood flow. Even in 
the presence of preserved tracer distribution and retention, 
regional dissynergies can produce false tracer perfusion defects 
through the "partial volume effect." However, in the present 
study the explanation of a "false" perfusion defect from 
abnormal segmental contraction seems less likely. Different 
from group 2 patients who showed no delayed improvement i  
perfusion and contraction at study 2, group 1 patients howed 
better egional and ventricular function at study 1 despite the 
presence of a comparable perfusion defect size between the 
two groups of patients at study 1. 
The salvaged myocardium, which is represented by the 
difference between the jeopardized territory and the residual 
damaged area, has been demonstrated (39,40) to be the main 
determinant of postinfarction ischemia. It is important to be 
aware that an imaging procedure that overestimates the size of 
the scar could lead to the underestimation f the extent of the 
still viable perinecrotic tissue at risk. In our serial evaluation, 
some underestimation f the extent of reversible hypoperfu- 
sion occurred at study 1 as a result of overestimating the 
scarred area. In 28 (70%) of 40 group 1 patients, the extent of 
the reversible tracer uptake defect was significantly greater 6
months later. However, the greater ischemic burden was 
mainly associated with the viable perinecrotic area, which 
showed "fixed" sestamibi uptake reduction (and was errone- 
ously interpreted as scarred) at study 1. The speculation of a 
delayed improvement of the blood flow to the perinecrotic 
area in group 1 patients could also explain why their stress- 
induced hypoperfusion was significantly reduced at study 2. By 
contrast, rest and stress hypoperfusion defects remained sub- 
stantially unchanged ingroup 2. In fact, we were unable to find 
significant differences in terms of TIMI grade of the infarct- 
related vessel flow and the presence of collateral circulation 
between the two groups. However, the limitations of coronary 
angiography in the assessment of collateral vessels are well 
known (41,42). 
Limitations of the study. Only male patients with anterior 
Q wave myocardial infarction and rest ejection fraction values 
>25% were selected. Furthermore, patients with unstable 
coronary artery disease or with low-threshold ischemia were 
not considered, and patients with extensive coronary artery 
disease did not complete the serial evaluation. Thus, the 
observed results do not necessarily apply to all patients with 
recent myocardial infarction. Another limitation could stem 
from the fact that coronary angiography was carried out at an 
average of 3 months from the first scintigraphic evaluation. 
Although angiography was performed after a long interval 
from the acute phase and in patients in clinically stable 
condition, it is possible that the status of the infarct-related and 
collateral vessels at the time of the angiogram ay have been 
different from that at the time of the study 1 evaluations, 
contributing tothe lack of relation observed between sestamibi 
defect reduction and vessel patency or collateral vessels. 
Conclusions. In patients with stable coronary artery dis- 
ease evaluated by serial sestamibi imaging after myocardial 
infarction, a late reduction of the rest tracer defect may occur. 
Perinecrotic areas that appear to be scarred 5 weeks after 
acute infarction can appear viable 6 months later, causing an 
apparent increase in the stress-induced reversible perfusion 
defect. This should be taken into account when an even earlier 
stress sestamibi perfusion scintigraphy (i.e. at predischarge) is 
used to assess the residual ischemic burden. 
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Comazzi for contributions to the data analysis; and Rosemary Allpress and 
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